Ohr Pharmaceutical, Inc. (OHRP)

[nupapa]

Annual Report out - note about RS:
The Company has filed a definitive proxy statement in connection with special meeting of stockholders to be held on January 18, 2019, at which the Company’s stockholders will vote to approve an amendment to the Company’s certificate of incorporation to effect a reverse stock split of the Company’s common stock at a split ratio of not less than one-for-three and not more than one-for-twenty, to be effective, if at all, at such time as the Company’s Board of Directors shall determine in its sole discretion. We cannot provide any assurances that the stockholders will approve the reverse stock split at the special meeting.

So the shareholders could deny it, in light of the announced merger. Nothing so far has been canceled.